HIV and AIDS in South Asia : An Economic Development Risk
This book offers an original perspective on HIV and AIDS as a development issue in South Asia, a region with a heterogeneous epidemic and estimated national HIV prevalence rates of up to 0.5 percent. The analysis challenges the common perception of...
Main Authors: | , |
---|---|
Format: | Publication |
Language: | English |
Published: |
World Bank
2012
|
Subjects: | |
Online Access: | http://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000334955_20090227085524 http://hdl.handle.net/10986/2598 |
Summary: | This book offers an original perspective
on HIV and AIDS as a development issue in South Asia, a
region with a heterogeneous epidemic and estimated national
HIV prevalence rates of up to 0.5 percent. The analysis
challenges the common perception of HIV and AIDS, which has
been shaped to a large extent by analysis of HIV and AIDS in
regions with much higher prevalence rates. The chapters,
most of which were commissioned specifically for this
volume, can be grouped in three broad themes - the
epidemiology of HIV and prevention strategies (chapters one
and two), economic and development impacts of HIV and AIDS
(chapters three and four), and the implications of HIV and
AIDS for the health sector (chapters five and six). Within
each theme, one chapter provides a more general discussion
of the respective issues in the region (chapters one, three,
and five), and one chapter highlights aspects of the
respective issue in one particular country (with chapter two
dealing with HIV in Afghanistan, and chapters four and six
discus sing aspects of the impact of or the response to HIV
and AIDS in India). Regarding the broad development themes
identified by this book, chapters one and two highlight the
epidemiological risks. Chapter three surveys the
intersection of HIV and AIDS and key development objectives,
and is complemented by chapters four and five. The
forward-looking discussion of the challenges of scaling up
(chapter five) is complemented by an analysis of the costs
of antiretroviral treatment (ART) in India (chapter six) and
a cross-country analysis of access to treatment (in chapter three). |
---|